Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.76 |
| ▸ | ADH1C | P00326 | 1/20 | 0.76 |
| ▸ | ADH1A | P07327 | 1/20 | 0.76 |
| ▸ | ADH7 | P40394 | 1/20 | 0.76 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8763263 | 0.92 | ADH1B (0.67) | ADH1BADH1CADH1AADH7ALOX5 | |
| SCHEMBL1486309 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7ALOX5 | |
| SCHEMBL3306571 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7ALDH1A1 | |
| SCHEMBL26832960 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7ALOX5 | |
| SCHEMBL5221625 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7KMT2A | |
| SCHEMBL513192 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7ALOX5 | |
| SCHEMBL17503962 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7 | |
| SCHEMBL4633463 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7KMT2A | |
| SCHEMBL43651 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7ALDH1A1 | |
| SCHEMBL349260 | 0.88 | ADH1B (0.61) | ADH1BADH1CADH1AADH7KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023230541-A1 | PIPERAZINE DERIVATIVES USEFUL IN HIV THERAPY | VIIV HEALTHCARE COMPANY (US) | 2023-11-30 | — | — | WO | disclosed |
| EP-0349195-B1 | Direct synthesis by cationic polymerization of nitrogen-containing polymers | EXXON CHEMICAL PATENTS INC (US) | 1997-05-21 | — | — | EP | disclosed |
| US-5444135-A | Polymerization and functionalization with nitrogen-containing functional groups occur simultaneously | EXXON CHEMICAL PATENTS INC. (US) | 1995-08-22 | — | — | US | disclosed |
| EP-0492145-B1 | Process for producing xylylene diisocyanate | MITSUBISHI GAS CHEMICAL CO (JP) | 1995-02-01 | — | — | EP | disclosed |
| US-5336745-A | Terminally-substituted polymeric compositions from cationically polymerizable monomers and initiators | EXXON CHEMICAL PATENTS INC. (US) | 1994-08-09 | — | — | US | disclosed |
| US-5196572-A | Thermal decomposition of xylylene dicarbamate with tin and/or antimony containing catalyst | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1993-03-23 | — | — | US | disclosed |
| EP-0492145-A2 | Process for producing xylylene diisocyanate | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1992-07-01 | — | — | EP | disclosed |
| US-5032653-A | Catalysts | EXXON CHEMICAL PATENTS, INC. (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0349195-A2 | Direct synthesis by cationic polymerization of nitrogen-containing polymers | EXXON CHEMICAL PATENTS INC. (US) | 1990-01-03 | — | — | EP | disclosed |